• 

  MCC Therapeutics, Inc. will present Phase 1 Clinical Results of MCCSA2 at the World Bronchiectasis Conference (WBC2026) in Hanover, Germany

  Published On: June 24, 2026
• 

  MCC Therapeutics announces the Publication of its Scientists’ Paper in the Journal of Clinical Investigation

  Published On: June 5, 2026
• 

  New hope from old drugs for cystic fibrosis: startup explores combination therapy

  Published On: October 7, 2025